Table 2.
Upstream regulator analysis (Ingenuity Pathway Analysis) for DMSO (96 h versus 6 h) and 0.1 μM at 96 h. Only the top predicted upstream regulators are shown (six for DMSO and three for 0.1 μM ATRA at 96 h). Upstream regulators that were not assigned a predicted activation state are omitted from this table.
Concentration | Upstream Regulator | Expr Log Ratio | Predicted Activation State | Activation Z-Score | P-value of Overlap |
---|---|---|---|---|---|
| |||||
DMSO (96 h v 6 h) | progesterone | Activated | 2.148 | 1.33E-15 | |
DMSO (96 h v 6 h) | EOMES | 6.906 | Activated | 3.685 | 7.46E-15 |
DMSO (96 h v 6 h) | SOX2 | 0 | Inhibited | −2.731 | 7.95E-14 |
DMSO (96 h v 6 h) | topotecan | Inhibited | −3.923 | 1.85E-12 | |
DMSO (96 h v 6 h) | dexamethasone | Activated | 3.013 | 4.58E-12 | |
DMSO (96 h v 6 h) | tretinoin | Activated | 2.51 | 1.01E-11 | |
0.1 μM (96 h) | EOMES | −1.017 | Inhibited | −2.549 | 1.22E-15 |
0.1 μM (96 h) | dexamethasone | Inhibited | −2.512 | 1.62E-13 | |
0.1 μM (96 h) | LHX1 | −2.049 | Inhibited | −2.774 | 2.81E-11 |